Back to Search
Start Over
Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders
- Source :
- Molecular Genetics and Metabolism Reports, Vol 15, Iss , Pp 71-73 (2018)
- Publication Year :
- 2018
- Publisher :
- Elsevier, 2018.
-
Abstract
- Totally implantable vascular access devices (TIVADs) are commonly used in conjunction with enzyme replacement therapy (ERT) for lysosomal storage disorders (LSDs). This case series describes potential complications associated with long-term TIVAD use, such as compromise of skin integrity, infection, or port failures. Best practices and skilled specialists are essential for minimizing complications from long-term TIVAD use for ERT. Keywords: Mucopolysaccharidosis, Enzyme replacement therapy, Totally implantable venous access device, Lysosomal storage disorder
- Subjects :
- Medicine (General)
R5-920
Biology (General)
QH301-705.5
Subjects
Details
- Language :
- English
- ISSN :
- 22144269
- Volume :
- 15
- Issue :
- 71-73
- Database :
- Directory of Open Access Journals
- Journal :
- Molecular Genetics and Metabolism Reports
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.bba806f0f346248ca095390380ac63
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.ymgmr.2018.02.007